Your browser doesn't support javascript.
loading
A higher number of infused CD34(+) cells has a positive impact on the clinical outcome after related PBSC transplantation.
Maie, K; Fuji, S; Tajima, K; Tatsuno, M; Yamagata, S; Takahashi, N; Ueda, R; Hashimoto, H; Takano, K; Inoue, Y; Ito, A; Hayashi, Y; Okinaka, K; Kurosawa, S; Kim, S-W; Tanosaki, R; Heike, Y; Yamashita, T; Fukuda, T.
Afiliação
  • Maie K; 1] Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan [2] Department of Hematology, University of Tsukuba, Tsukuba, Japan.
  • Fuji S; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
  • Tajima K; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
  • Tatsuno M; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
  • Yamagata S; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
  • Takahashi N; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
  • Ueda R; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
  • Hashimoto H; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
  • Takano K; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
  • Inoue Y; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
  • Ito A; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
  • Hayashi Y; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
  • Okinaka K; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
  • Kurosawa S; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
  • Kim SW; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
  • Tanosaki R; Department of Blood Transfusion and Cellular Therapy, National Cancer Center Hospital, Tokyo, Japan.
  • Heike Y; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
  • Yamashita T; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
  • Fukuda T; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
Bone Marrow Transplant ; 49(8): 1113-5, 2014 Aug.
Article em En | MEDLINE | ID: mdl-24797181
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos CD34 / Neoplasias Hematológicas / Condicionamento Pré-Transplante / Transplante de Células-Tronco de Sangue Periférico Tipo de estudo: Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos CD34 / Neoplasias Hematológicas / Condicionamento Pré-Transplante / Transplante de Células-Tronco de Sangue Periférico Tipo de estudo: Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Ano de publicação: 2014 Tipo de documento: Article